 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
Volume 17, Number 24, Issue of December 15, 1997 pp. 9473-9480
Modulation of Hypothalamic-Pituitary-Adrenal Function by Transgenic Expression of Interleukin-6 in the CNS of Mice
Received July 30, 1997; revised Sept. 29, 1997; accepted Oct. 1, 1997.
Jacob Raber, Ross D. O'Shea, Floyd E. Bloom, and Iain L. Campbell Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037
Interleukin-6 (IL-6) and IL-6 receptor mRNA and protein have been reported in different brain regions under normal and pathophysiological conditions. Although much is known about the hypothalamic-pituitary-adrenal (HPA) axis stimulation after acute administration, less is known about the chronic effects of IL-6 on the function of the HPA axis. In the present study, we examined the function of the HPA axis in transgenic mice in which constitutive expression of IL-6 under the control of the glial fibrillary acidic protein (GFAP) promoter was targeted to astrocytes in the CNS. GFAP-IL6 mice heterozygous or homozygous for the IL-6 transgene had normal basal plasma corticosterone levels but, after restraint stress, showed abnormally increased levels in a gene dose-dependent manner. The increased plasma corticosterone levels in the IL-6 transgenic mice were associated with increased adrenal corticosterone content and hyperplasia of both adrenal cortex and medulla. Notably, plasma adrenocorticotrophic hormone (ACTH) levels and pituitary ACTH content were either not changed or decreased in these mice, whereas plasma arginine vasopressin (AVP) was increased, supporting a role for AVP in response to acute immobilization stress. The reduced ACTH response together with the adrenal hyperplasia in the IL-6 transgenic mice suggests direct activation at the level of the adrenal gland that may be directly activated by AVP or sensitized to ACTH. A similar mechanism may play a role in the blunted ACTH response and elevated corticosterone levels under pathophysiological conditions observed in humans with high brain levels of IL-6.
Key words: interleukin-6; hypothalamus; pituitary; adrenal gland; ACTH; corticosterone; HPA axis; transgenic
This article has been cited by other articles:
S. Gaupp, B. Cannella, and C. S. Raine
Amelioration of Experimental Autoimmune Encephalomyelitis in IL-4R{alpha}-/- Mice Implicates Compensatory Up-Regulation of Th2-Type Cytokines
Am. J. Pathol., July 1, 2008; 173(1): 119 - 129.
[Abstract] [Full Text] [PDF]
T. Gonzalez-Hernandez, D. Afonso-Oramas, I. Cruz-Muros, P. Barroso-Chinea, P. Abreu, M. del Mar Perez-Delgado, N. Rancel-Torres, and M. del Carmen Gonzalez
Interleukin-6 and Nitric Oxide Synthase Expression in the Vasopressin and Corticotrophin-releasing Factor Systems of the Rat Hypothalamus
J. Histochem. Cytochem., April 1, 2006; 54(4): 427 - 441.
[Abstract] [Full Text] [PDF]
M. N. Silverman, A. H. Miller, C. A. Biron, and B. D. Pearce
Characterization of an Interleukin-6- and Adrenocorticotropin-Dependent, Immune-to-Adrenal Pathway during Viral Infection
Endocrinology, August 1, 2004; 145(8): 3580 - 3589.
[Abstract] [Full Text] [PDF]
M. T. Ghorbel, G. Sharman, M. Leroux, T. Barrett, D. M. Donovan, K. G. Becker, and D. Murphy
Microarray Analysis Reveals Interleukin-6 as a Novel Secretory Product of the Hypothalamo-neurohypophyseal System
J. Biol. Chem., May 23, 2003; 278(21): 19280 - 19285.
[Abstract] [Full Text] [PDF]
O. A. Tjurmina, I. Armando, J. M. Saavedra, D. S. Goldstein, and D. L. Murphy
Exaggerated Adrenomedullary Response to Immobilization in Mice with Targeted Disruption of the Serotonin Transporter Gene
Endocrinology, December 1, 2002; 143(12): 4520 - 4526.
[Abstract] [Full Text] [PDF]
L. Vallieres, I. L. Campbell, F. H. Gage, and P. E. Sawchenko
Reduced Hippocampal Neurogenesis in Adult Transgenic Mice with Chronic Astrocytic Production of Interleukin-6
J. Neurosci., January 15, 2002; 22(2): 486 - 492.
[Abstract] [Full Text] [PDF]
A. Chouker, M. Thiel, V. Baranov, D. Meshkov, A. Kotov, K. Peter, K. Messmer, and F. Christ
Simulated microgravity, psychic stress, and immune cells in men: observations during 120-day 6{degrees} HDT
J Appl Physiol, May 1, 2001; 90(5): 1736 - 1743.
[Abstract] [Full Text] [PDF]
B. R. Lackey, S. L. Gray, and D. M. Henricks
Does the Insulin-Like Growth Factor System Interact with Prostaglandins and Proinflammatory Cytokines During Neurodegeneration?
Experimental Biology and Medicine, May 1, 2000; 224(1): 20 - 27.
[Abstract] [Full Text]
J. Raber, S. F. Akana, S. Bhatnagar, M. F. Dallman, D. Wong, and L. Mucke
Hypothalamic-Pituitary-Adrenal Dysfunction in Apoe-/- Mice: Possible Role in Behavioral and Metabolic Alterations
J. Neurosci., March 1, 2000; 20(5): 2064 - 2071.
[Abstract] [Full Text] [PDF]
L. Vallières and S. Rivest
Interleukin-6 Is a Needed Proinflammatory Cytokine in the Prolonged Neural Activity and Transcriptional Activation of Corticotropin-Releasing Factor during Endotoxemia
Endocrinology, September 1, 1999; 140(9): 3890 - 3903.
[Abstract] [Full Text]
H. Saito and J. Papaconstantinou
Age-associated Differences in Cardiovascular Inflammatory Gene Induction during Endotoxic Stress
J. Biol. Chem., July 27, 2001; 276(31): 29307 - 29312.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|